Revero, Jessie .

HRN: 16-82-34  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/01/2022
11/08/2022
IV
500 Mg
Q8
Acute Gastritis; T/C UTI
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary TractIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes